POLYMED.NS Profit & Loss
Poly Medicure Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:43
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹11.15 Bn | ₹13.76 Bn | ₹16.70 Bn | ₹18.75 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.36 Bn | ₹0.59 Bn | ₹0.89 Bn | ₹1.20 Bn | OtherIncome |
| Total Income | ₹11.51 Bn | ₹14.35 Bn | ₹17.59 Bn | ₹19.95 Bn | Income |
| Cost of Materials Consumed | ₹4.24 Bn | ₹4.65 Bn | ₹5.71 Bn | ₹5.99 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.05 Bn | ₹0.07 Bn | ₹0.08 Bn | ₹0.05 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.24 Bn | ₹0.11 Bn | ₹-0.25 Bn | ₹-0.08 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹2.03 Bn | ₹2.46 Bn | ₹3.02 Bn | ₹4.02 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.09 Bn | ₹0.11 Bn | ₹0.12 Bn | ₹0.18 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹0.57 Bn | ₹0.64 Bn | ₹0.83 Bn | ₹1.16 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹2.41 Bn | ₹2.89 Bn | ₹3.61 Bn | ₹4.34 Bn | OtherExpenses |
| Total Expenses | ₹9.16 Bn | ₹10.93 Bn | ₹13.12 Bn | ₹15.67 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹2.36 Bn | ₹3.42 Bn | ₹4.47 Bn | ₹4.29 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹-0.07 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹2.36 Bn | ₹3.42 Bn | ₹4.47 Bn | ₹4.22 Bn | ProfitBeforeTax |
| Tax Expense | ₹0.58 Bn | ₹0.86 Bn | ₹1.14 Bn | ₹1.07 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹1.79 Bn | ₹2.58 Bn | ₹3.39 Bn | ₹3.21 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹1.79 Bn | ₹2.58 Bn | ₹3.39 Bn | ₹3.22 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹18.69 | ₹26.92 | ₹34.13 | ₹31.79 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹18.67 | ₹26.90 | ₹34.11 | ₹31.75 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from POLYMED.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).